Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group (Q44491255)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group |
scientific article |
Statements
1 reference
Docetaxel and gemcitabine combination, as first-line treatment, in patients with extensive disease small-cell lung cancer. A phase II study of the Hellenic Cooperative Oncology Group (English)
1 reference
1 reference
George Fountzilas
1 reference
Helen Gogas
1 reference
Pavlos Papakostas
1 reference
Hellenic Cooperative Oncology Group
1 reference
Epaminondas Samantas
1 reference
Nicholas Pavlidis
1 reference
Christos Kiamouris
1 reference
Dimosthenis-Vasilios Skarlos
1 reference
Paraskevas Kosmidis
1 reference
Charalambos Bacoyiannis
1 reference
Georgios Klouvas
1 reference
1 July 2003
1 reference
1 reference
41
1 reference
1
1 reference
107-111
1 reference
Identifiers
1 reference
1 reference